327183-32-4

Basic information

• Product Name: Chroman-8-carbaldehyde, 95%
• Synonyms: Chroman-8-carbaldehyde, 95%;3,4-dihydro-2H-chroMene-8-carbaldehyde;chromane-8-carbaldehyde
• CAS NO: 327183-32-4
• Molecular Formula: C₁₀H₁₀O₂
• Molecular Weight: 162.1852
• Mol File: 327183-32-4.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Chroman-8-carbaldehyde, 95%(CAS DataBase Reference)
• NIST Chemistry Reference: Chroman-8-carbaldehyde, 95%(327183-32-4)
• EPA Substance Registry System: Chroman-8-carbaldehyde, 95%(327183-32-4)

Safety Data

• Hazardous Substances Data: 327183-32-4(Hazardous Substances Data)

Usage

General Description

Chroman-8-carbaldehyde, also known as 8-Formylchromone, is a chemical compound with a molecular formula C11H8O2. It is a yellow crystalline solid with a strong odor, and is typically used as a building block in the synthesis of various pharmaceuticals and organic compounds. It is commonly utilized as a reagent in organic synthesis for the preparation of heterocyclic compounds, and also finds applications in the production of dyes, fragrances, and perfumes. This chemical is available in a 95% purity, making it suitable for use in research laboratories and industrial settings for a wide range of applications.

Upstream product

• 1001671-65-3 (2,6-dibromophenyl) (2-chloropropyl) ether 
• 68-12-2 N,N-dimethyl-formamide 
• 493-08-3 chromane 
• 206347-33-3 1,3-Dibromo-2-(3-bromo-propoxy)-benzene 
• 608-33-3 2,6-dibromophenol 

Downstream Products

• 1037206-62-4 C₂₅H₂₁FN₂O₄ 
• 1037206-59-9 C₂₆H₂₃FN₂O₄ 
• 1037206-64-6 C₂₆H₂₄FN₃O₅S 
• 1037205-45-0 C₂₅H₂₂FN₃O₅S 

Relevant articles and documents

The Key Role of the Nonchelating Conformation of the Benzylidene Ligand on the Formation and Initiation of Hoveyda-Grubbs Metathesis Catalysts

Experimental studies of Hoveyda-Grubbs metathesis catalysts reveal important consequences of substitution at the 6-position of the chelating benzylidene ligand. The structural modification varies conformational preferences of the ligand that affects its exchange due to the interaction of the coordinating site with the ruthenium center. As a consequence, when typical S-chelated systems are formed as kinetic trans-Cl2 products, for 6-substituted benzylidenes the preference is altered toward direct formation of thermodynamic cis-Cl2 isomers. Activity data and reactions with tricyclohexylphosphine (PCy3) support also a similar scenario for O-chelated complexes, which display fast trans-Cl2?cis-Cl2 equilibrium observed by NMR EXSY studies. The presented conformational model reveals that catalysts, which cannot adopt the optimal nonchelating conformation of benzylidene ligand, initiate through a high-energy associative mechanism.

Probing of the ligand anatomy: Effects of the chelating alkoxy ligand modifications on the structure and catalytic activity of ruthenium carbene complexes

Structural modifications of the Hoveyda-Grubbs ruthenium metathesis complex via electronic and structural withdrawing of the chelating alkoxy ligand were investigated. By decreasing the donor properties of the oxygen atom, an acceleration in catalytic act

4,9-ETHANO-BENZO(F)ISOINDOLE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS

Novel products of formula (I): STR1 preparation thereof and pharmaceutical compositions containing said products are disclosed. In formula (I), R is a group of formula (CH 2) m X 1 (CH 2) n Z, where X 1 is a simple bond or O or S, n is 0 or 1 and n is 0,